Human Immunodeficiency Virus 1 (HIV-1) PhenoSense GT Plus Integrase (Monogram Phenotype + Genotype)
Human Immunodeficiency Virus 1 (HIV-1) PhenoSense GT Plus Integrase (Monogram Phenotype + Genotype)-994
PhenoSense GT Plus Integrase
Determines viral phenotype and genotype resistance to four classes of commonly prescribed antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), nonnucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors (PI), and integrase inhibitors (INI).
Submission of the minimum volume does not allow for repeat testing
- Collect specimen in three lavender-top (EDTA) tubes
- Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
- Spiun within six (6) hours of sample collection
- Transfer plasma to one or more Transfer vial/tube for small volume specimens (Sarstedt), labelled as EDTA plasma
- Freeze
Frozen (strict) – 14 days
Refrigerated - NO
Ambient - NO
- Quantity not sufficient for analysis (QNS)
- Heparinized plasma
- Nonfrozen specimens specimens exposed to repeated freeze/thaw cycles
- Specimen received in "pop-top" or "snap-cap" tube
Phenotype: polymerase chain reaction (PCR) amplification and viral culture Genotype: polymerase chain reaction (PCR) and DNA sequencing
See report
This assay is a combined assay in which HIV resistance phenotype and HIV resistance genotype is performed.
This test should be used for patients with documented HIV-1 infection and viral loads ≥500 copies/mL. If there is insufficient virus to produce results, HIV-1 RNA quantitation will be performed to confirm viral load, for an additional fee.
87901
87903
87904 x 16
87906